Navigation Links
New nanoparticle vaccine is more effective but less expensive
Date:9/17/2007

ced, and they are easy to transport.

The group is collaborating with the Swiss Tropical Institute in Basel to determine the strength and duration of the immune response in the context of a nanoparticle malaria vaccine. Toxicity studies are also in the works. Swartz says that the team is also planning to use this technique to target cancer cells.

If, as we hope, this vaccine technique can confer sustained immunity with a single injection for around a dollar a dose, without toxic side effects, it could have a real impact on public health, in the developing world as well as right here at home, says Swartz. More study is required to achieve these goals, she adds, but we have every reason to believe this technique could be in use within five years.


'/>"/>

Contact: Mary Parlange
mary.parlange@epfl.ch
41-216-916-113
Ecole Polytechnique Fd rale de Lausanne
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. DNA Molecules Used To Assemble Nanoparticles
2. Imaging Lymph Nodes with Nanoparticles
3. Taking Aim With Nanoparticle PEBBLEs
4. Probing The Promise And Perils Of Nanoparticles
5. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
6. Probing the promise and perils of nanoparticles
7. Nanoparticles offer new hope for detection and treatment
8. Nanoparticle Breast Cancer Drug Approved by FDA
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Using nanoparticles, in vivo gene therapy activates brain stem cells
11. Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... The Institute for Translational Medicine and Therapeutics, 7th ... Personalization and the Science of Scale, to be ... direct relevance to translational science. ITMAT is part ... University of Pennsylvania. , Speakers will include those ...
... a humane option for the control of feral and ... issued by the International Society of Feline Medicine (ISFM) ... published by SAGE. According to the society, which ... Care, culling to control cat populations is also rarely ...
... screening shellfish for fungal toxins is important, say scientists. ... Society for Applied Microbiology (SfAM) journal, Letters in ... contamination by strains of Penicillium fungus, bivalve ... at much higher levels that are found in the ...
Cached Biology News:Lab-on-a-chip tech, brain mapping & microbiome highlighted at translational med meeting 2ISFM takes a stand on welfare of unowned cats 2
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ... Therapy Market, 2015 - 2025" report to their ... report provides an extensive study on the marketed and ... carried out in this field for over a decade ... in Asian markets; one approved in the EU). There ...
(Date:3/3/2015)... California (PRWEB) March 03, 2015 Crown ... service company, has launched a new Life Science division ... for preclinical research. , The first products released ... isotype controls, and soon to be released in vivo ... will continue to expand their life science portfolio with ...
(Date:3/3/2015)... March 3, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... scientific journal, Expert Opinion on Biological Therapy , ... Zhenggang Zhang , at the Henry Ford Hospital ... Thymosin beta 4 (TB4) has the capacity to promote ... or more post-injury, leading to neurological recovery in each ...
(Date:3/3/2015)... Liberty Corner, New Jersey (PRWEB) March 03, 2015 ... in NJ, has announced today that it has ... DE. Terms of the transaction were not ... engineering consulting services to the energy sector including ... gas, alternative energy, and fossil and nuclear power ...
Breaking Biology Technology:Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7Crown Bioscience Launches Life Science Product Catalog 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
... in Quality by Design Initiative for Protein Therapeutics - ... Sciences, Inc. (Nasdaq: CALP ), a leading ... life sciences research, today launched the Staccato Protein Workstation ... therapeutics and biogenerics. , , With a ...
... Md., June 29 Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... 3000 Index as part of the annual reconstitution of ... , , "Investors recognize the Russell 3000 as ...
... ever involving patients with cutaneous T-cell lymphoma on schedule ... RADNOR, Pa., June 29 Yaupon Therapeutics, a privately ... enrollment for a pivotal Phase 2 clinical trial for ... (CTCL - stages 1-2a). The study, which is ...
Cached Biology Technology:Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 2Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 3Micromet Added to Russell 3000 Index 2Micromet Added to Russell 3000 Index 3Micromet Added to Russell 3000 Index 4Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma 2
... instrument can be used as a fully ... Manager Software provides the means to record ... instrument. These data can then be copied ... as Microsoft Excel or Lotus 123, or ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... Oligo Microarray Kit (V2), 2 x ... characterize expression of many thousands of ... during important biological processes. Each microarray ... known ORFs from the S288C strain ...
... an intuitive, easy-to-use operating environment ... data handling, and integration with ... include data acquisition, re-analysis, custom ... both standalone and network environments. ...
Biology Products: